Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Sheena Pinto"'
Autor:
Montserrat Arnan, Pau Montesinos, Stéphane de Botton, Christian Recher, Lydia Wunderle, Michael Emig, Andreas Harstrick, Kerstin Pietzko, Sheena Pinto, Paulien Ravenstijn, Naval Daver
Publikováno v:
HemaSphere, Vol 7, p e2404792 (2023)
Externí odkaz:
https://doaj.org/article/b4d7a74d16094c5d9e7ece66f935eeac
Autor:
Jason A. Carter, Léonie Strömich, Matthew Peacey, Sarah R. Chapin, Lars Velten, Lars M. Steinmetz, Benedikt Brors, Sheena Pinto, Hannah V. Meyer
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
The thymus generates all T cells, including those that underly autoimmune diseases. Here, using deep sequencing, the authors profile human medullary thymic epithelial cells and establish a web portal to query their transcriptome, which may serve as a
Externí odkaz:
https://doaj.org/article/cd8d5709b0484a3e9ece600be3ca2e46
Autor:
Uwe Reusch, Joachim Koch, Sheena Pinto, Susanne Wingert, Jens Pahl, Armin Beez, Sabrina Purr, Arndt Schottelius
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6e5e4f7765b34750811e4f80882b6f79
Autor:
Joachim Koch, Sheena Pinto, Susanne Wingert, Jens Pahl, Chiara Zambarda, Karolin Guldevall, Christian Breunig, Damien Toullec, Jacopo Fontana, Björn Önfelt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/dde28aa9a42d4f86ae8c60c460702adf
Publikováno v:
Trends in immunology. 43(11)
Bi-, tri- and multispecific antibodies have enabled the development of targeted cancer immunotherapies redirecting immune effector cells to eliminate malignantly transformed cells. These antibodies allow for simultaneous binding of surface antigens o
Autor:
Chiara Zambarda, Karolin Guldevall, Damien Toullec, Susanne Wingert, Christian Breunig, Sheena Pinto, Jacopo Fontana, Joachim Koch, Björn Önfelt
Publikováno v:
Cancer Research. 83:2950-2950
Antibody-Dependent Cellular Cytotoxicity (ADCC) is a powerful mechanism of Natural Killer (NK) cells to kill antibody-opsonized target cells. However, ADCC mediated by conventional antibodies has its limitations in killing of tumor cells commonly bei
Autor:
Chiara Zambarda, Karolin Guldevall, Christian Breunig, Damien Toullec, Jacopo Fontana, Sheena Pinto, Jens Pahl, Susanne Wingert, Joachim Koch, Björn Önfelt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe use of bispecific natural killer (NK) cell engagers has emerged as a successful strategy for immune cell activation and killing of tumor cells through antibody-dependent cellular cytotoxicity (ADCC). Among these, tetravalent, bispecific
Autor:
Maki Nakayama, Maikel Luis Colli, Yann Verdier, Noemi Brusco, Lut Overbergh, Mark J. Mamula, Aïsha Callebaut, Joëlle Vinh, Guido Sebastiani, Georgia Afonso, Laura Nigi, Matthieu Giraud, Barbara Brandao, Zhicheng Zhou, Sylvaine You, Alexia Carré, Mijke Buitinga, Sheena Pinto, Marie Eliane Azoury, Decio L. Eizirik, Francesco Dotta, Chantal Mathieu, Søren Buus, Roberto Mallone, Fatoumata Samassa, Ana Ines Lalanne, Magali Irla
Publikováno v:
Diabetes
Diabetes, American Diabetes Association, 2021, pp.db210259. ⟨10.2337/db21-0259⟩
Diabetes, American Diabetes Association, 2021, pp.db210259. ⟨10.2337/db21-0259⟩
In type 1 diabetes, autoimmune β-cell destruction may be favored by neo-antigens harboring post-translational modifications such as citrullination. We studied the recognition of native and citrullinated glucose-regulated protein (GRP)78 peptides by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a38375b241b82cebe35b607398e6eea
https://doi.org/10.2337/figshare.16654669
https://doi.org/10.2337/figshare.16654669
Autor:
Marie Eliane, Azoury, Fatoumata, Samassa, Mijke, Buitinga, Laura, Nigi, Noemi, Brusco, Aïsha, Callebaut, Matthieu, Giraud, Magali, Irla, Ana Ines, Lalanne, Alexia, Carré, Georgia, Afonso, Zhicheng, Zhou, Barbara, Brandao, Maikel L, Colli, Guido, Sebastiani, Francesco, Dotta, Maki, Nakayama, Decio L, Eizirik, Sylvaine, You, Sheena, Pinto, Mark J, Mamula, Yann, Verdier, Joelle, Vinh, Soren, Buus, Chantal, Mathieu, Lut, Overbergh, Roberto, Mallone
Publikováno v:
Diabetes
In type 1 diabetes, autoimmune β-cell destruction may be favored by neoantigens harboring posttranslational modifications (PTMs) such as citrullination. We studied the recognition of native and citrullinated glucose-regulated protein (GRP)78 peptide
Autor:
Joëlle Vinh, Aurore Pais, Sylvaine You, Etienne Larger, Decio L. Eizirik, Maikel Luis Colli, Laure Alexandre-Heymann, Danièle Dubois-Laforgue, Roberto Mallone, Søren Buus, Georgia Afonso, Graziella Bruno, Mahmoud Tarayrah, Cassandra Lavaud, Gonzalez-Duque Sergio, Jean-Paul Beressi, Sheena Pinto, Marie Eliane Azoury, Claire Maillard, Verdier Yann
Publikováno v:
Diabetes
Diabetes, 2020, 69 (12), pp.2678-2690. ⟨10.2337/db20-0013⟩
Diabetes, American Diabetes Association, 2020, 69 (12), pp.2678-2690. ⟨10.2337/db20-0013⟩
Diabetes, 2020, 69 (12), pp.2678-2690. ⟨10.2337/db20-0013⟩
Diabetes, American Diabetes Association, 2020, 69 (12), pp.2678-2690. ⟨10.2337/db20-0013⟩
The antigenic peptides processed by β cells and presented through surface HLA Class I molecules are poorly characterized. Each HLA variant, e.g. the most common HLA-A2 and HLA-A3, carries some peptide-binding specificity. Hence, features that, despi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1a19452588c10d10f72a2c18829d5e
https://www.hal.inserm.fr/inserm-03312401
https://www.hal.inserm.fr/inserm-03312401